Cardiovascular health status and genetic risk in survivors of childhood neuroblastoma and nephroblastoma treated with doxorubicin: protocol of the pharmacogenetic part of the LESS-Anthra cross-sectional cohort study (Preprint)-Reference-Cited by-同舟云学术

Cardiovascular health status and genetic risk in survivors of childhood neuroblastoma and nephroblastoma treated with doxorubicin: protocol of the pharmacogenetic part of the LESS-Anthra cross-sectional cohort study (Preprint)

Published:2021-02-15 Issue: Volume: Page:
ISSN:1929-0748
Container-title:JMIR Research Protocols
language:en
Short-container-title:

Author:

Zolk Oliver^ORCID,von dem Knesebeck Annika,Graf Norbert^ORCID,Simon Thorsten^ORCID,Hero Barbara,Abdul-Khaliq Hashim,Abd El Rahman Mohamed,Spix Claudia,Mayer Benjamin,Elsner Susanne,Gebauer Judith,Langer Thorsten

Publisher

JMIR Publications Inc.

Subject

General Medicine

Reference17 articles.

1. Chronic Health Conditions in Adult Survivors of Childhood Cancer

2. Late Mortality Experience in Five-Year Survivors of Childhood and Adolescent Cancer: The Childhood Cancer Survivor Study

3. Female Sex and Higher Drug Dose as Risk Factors for Late Cardiotoxic Effects of Doxorubicin Therapy for Childhood Cancer

4. Late anthracycline cardiotoxicity after childhood cancer

5. Congestive Heart Failure After Treatment for Wilms’ Tumor: A Report From the National Wilms’ Tumor Study Group

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VersKiK: Study protocol of an observational registry-based study on the current state of follow-up care and adherence to follow-up guidelines after cancer in childhood or adolescence;Cancer Epidemiology;2023-12

2. The Role of RARG rs2229774, SLC28A3 rs7853758, and UGT1A6*4 rs17863783 Single-nucleotide Polymorphisms in the Doxorubicin-induced Cardiotoxicity in Solid Childhood Tumors;Journal of Pediatric Hematology/Oncology;2023-10-13

3. Risks of long-term mortality and chronic health conditions experienced by Wilms tumor survivors;Translational Pediatrics;2023-10

4. Cardiotoxicity and pharmacogenetics of doxorubicin in black Zimbabwean breast cancer patients;British Journal of Clinical Pharmacology;2023-01-27